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This work explores time-resolved emission imaging microscopy (TREM) for noninvasive imaging and mapping of live cells on a hitherto uncharted microsecond time scale. Simple robust molecules for this purpose have long been sought. We have developed highly emissive, synthetically versatile, and photostable platinum(II) complexes that make TREM a practicable reality. fluorescence microscopy ͉ time-resolved luminescence spectroscopy ͉ transition metal complexes ͉ cyclometalation U nderstanding chemical processes that underpin biological systems relies on technological and conceptual developments that permit noninvasive monitoring of biological processes in real time. Fluorescence microscopy is one of the most widely used tools in the biological sciences, benefiting from exquisite sensitivity, excellent spatial resolution, and unparalleled temporal resolution (1, 2) . It permits a breadth of investigations from interactions of single molecules to wholeorganism studies and relies on light emission from either endogenous fluorophores or external fluorescent probes to monitor the local environment and changes therein. Of the three fundamental emission parameters-intensity, wavelength, and lifetime-the vast majority of fluorescence imaging studies to date have been based on spatial variation of emission intensity or on wavelength changes (3, 4) . In contrast, lifetime-based approaches remain severely underexplored. Yet lifetime-based sensing and imaging is a powerful complement to the usual methods (5, 6) . A major benefit is that emission lifetimes are normally independent of concentration and can be calibrated absolutely, unlike intensity measurements, which are subject to error from fluctuations in the efficiency of delivery and detection of light.
Recent advances in fluorescence-lifetime detection techniques have made fluorescence lifetime imaging microscopy (FLIM) a reality (7) . To date, FLIM has been based primarily on endogenous molecules, such as the aromatic amino acid tryptophan (8) , and on fluorescent dyes including GFP-tagged proteins and fluorescein derivatives (9) , all of which have lifetimes of a few nanoseconds. The short lifetimes necessitate subnanosecond light sources and fast detectors, because (i) relatively small changes within the subnanosecond time scale need to be resolved; and (ii) it becomes essential to distinguish the fluorescence of the agent from autofluorescence that emanates from natural biological chromophores, also on the nanosecond time scale.
A significant step forward would be the development of time-resolved emission imaging microscopy (TREM), which uses longer time scales-hundreds of nanoseconds to microseconds. Long time scales offer improved discrimination through much larger changes in lifetime and by allowing time-gated experiments to distinguish from short-lived autofluorescence (10) . TREM does not need fast excitation or detection methods; on the contrary, it can be performed with nanosecond lasers and slower gated detectors. To date, the limiting factor that has inhibited the development of practicable TREM has been the chemistry rather than the optical technology. The fundamental constraint is the lack of cell-permeable, nontoxic luminescent probes with lifetimes in excess of Ϸ100 ns in aerated aqueous media at room temperature or above. Most phosphorescent organic molecules cannot be used under such conditions due to efficient quenching of their naturally long-lived triplet states.
Certain transition metal complexes can emit efficiently with lifetimes Ͼ100 ns from triplet excited states, because the formally spin-forbidden S 0 4 T 1 transition is promoted by the spin-orbit coupling associated with the heavy-metal atom. Steady-state cell images have been obtained recently by using ruthenium(II) and rhenium(I) complexes (11) (12) (13) . The temporal dimension has yet to be explored. Successful time-gated cell imaging with charge-neutral platinum porphyrins has been reported (14, 15) , however, the long excited-state lifetimes of Ϸ100 s lead to severe oxygen quenching and consequent cytotoxicity. The current work introduces a powerful combination of highly emissive charge-neutral platinum(II) complexes with time-resolved imaging in TREM. The Pt(II) complexes developed also meet other essential criteria for TREM agents, including chemical and photochemical stability, low cytotoxicity, and synthetic versatility for potential specific targeting. Photostability is of direct importance to biological imaging if implemented in combination with two-photon excitation (TPE). TPE is emerging as a versatile tool for noninvasive imaging of live cells and tissues. It excites chromophores in the visible region by using simultaneous absorption of two photons of low-energy light in the range 600-1100 nm of relative tissue transparency. This enables z axis imaging depths of hundreds of micrometers. The high photon flux used in TPE provides intrinsic spatial resolution but demands exceptional photostability of the chromophores used. Here, we demonstrate that the Pt(II) complexes developed easily have sufficient photostability for multiphoton excitation in live cells.
This article shows that TREM can be made a practicable reality by using highly emissive, photochemically robust transition-metal complexes for live-cell imaging and mapping.
Results and Discussion
Compounds Used and Photophysical Background. The imaging agents used are [PtLCl] (Fig. 1) , the Pt(II) complexes of the cyclometalating, terdentate, N^C^N-coordinating ligand 1,3-di(2-pyridyl)benzene and derivatives. These compounds can be readily synthesized in two steps from simple starting materials in high yields (20) . The core structure is easily derivatized at the central position of the ligand (R, Fig. 1 ) which allows for tuning of the emission over a wide spectral range from blue-green to orange (21) . It also offers a means for simple conjugation to biotargeting functionality; for example, biotin-appended complexes have been prepared via an amide linker, R ϭ CH 2 NHCO. The straightforward synthetic route makes this class of labels unprecedentedly accessible, especially when compared with organic phosphorescent probes.
We previously demonstrated that [PtLCl] absorb strongly in the UV region (350-380 nm, Ϸ10 4 mol Ϫ1 dm 3 cm Ϫ1 , with a weaker S 3 T band in the visible Ϸ490 nm, Ϸ200 mol Ϫ1 dm 3 cm Ϫ1 ) and are intensely luminescent in fluid solution at room temperature, in the range 480-600 nm. The quantum yields of emission (⌽ lum ) are 0.6-0.7 in degassed dichloromethane solution, remarkably high for platinum chromophores, in which the emissive excited state is frequently quenched by nonradiative decay via a low-lying, strongly antibonding d-d excited state (22, 23) . The high efficiency of luminescence can be rationalized in terms of the very strong ligand field associated with the rigid terdentate cyclometalating ligand, which raises the energy of d-d excited states, thereby diminishing or even eliminating this pathway of nonradiative decay. The emission of [PtLCl] is attributed to an excited state of predominant triplet intraligand -* character, in which there is sufficient contribution from the metal to achieve a lifetime of several microseconds. Thus, from the photophysical perspective, the complexes satisfy the requirements for time-resolved imaging on the time scale of hundreds of nanoseconds to microseconds. The sections that follow discuss investigations into their intracellular applicability. This article focuses on the simplest [PtL Viability, and Photostability. Three cell lines were selected because they spanned a range of phenotypes, namely, (i) a normal human cell type (dermal fibroblast; HDF) that can typically be cultured up to passages 8-9; (ii) a neoplastic human cell line that can be cultured indefinitely (melanoma; C8161); and (iii) an animal-derived cell line that can be cultured indefinitely (CHO). HDF cells were isolated from the dermis of a healthy patient undergoing elective surgery, C8161 cells were derived from a highly-metastatic secondary invasive melanoma, and the CHO line is a commonplace animal cell type used in many laboratories for genetic transfection and protein expression studies. All cells were mononucleated and adherent, and experimentation was undertaken on cells at all stages of the division cycle (G 1 , S, G 2 and M phases). This provided a basis for identifying general intracellular target labeling sites, through membrane permeability and relative biochemical affinity. The three cell types studied also enabled potential labeling discrepancies to be identified because of differences in neoplastic properties or species.
To determine whether [PtL 1 Cl] was potentially cytotoxic or altered cell viability, the metabolic activity of each cell type was examined by using an MTT assay after exposure to the complex {MTT ϭ 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide}. Concentrations of [PtL 1 Cl] in the range from 1 to 100 M were investigated with incubation times varying from 5 min to 24 h. These studies revealed that the cells were viable after 1 h of incubation with a 100 M solution of [PtL 1 Cl], with no significant decrease in metabolic activity (Fig. 2) . Exposure to a 100 M solution for 24 h caused a 90% reduction in the viability of CHO cells (Fig. S1) , and a 70% reduction in the viability of HDF cells.
ʈ The long-lived f-f excited states of some of the lanthanide(III) ions, in particular the visible emitters Eu(III) and Tb(III), are also attractive in time-resolved measurements and are already exploited in some in vitro assays (16, 17) . Lanthanide complexes have recently been used in imaging of live cells, although such studies to date have been confined to steady-state imaging (18, 19) . However, exposure to a 10 M solution did not cause significant reduction in cell viability even over a period of 24 h.
The low cytotoxicity of the complexes within the cells is, at first sight, rather surprising given that, in fluid organic solvents, [PtL 1 Cl] is a moderately efficient sensitizer of singlet oxygen (quantum yield for 1 ⌬ g O 2 formation is 0.4). This suggests that, within the cell, the complex is protected from diffusion-controlled quenching by oxygen, possibly by binding to hydrophobic environments of large biomolecules such as proteins or nucleic acids-a notion supported by the results of costaining studies, high-resolution images, and spectroscopic measurements described below. No photobleaching of the compound within the cells was observed under prolonged NIR (780 nm) or UV (390 nm) laser irradiation at an average power of 100 mW for 6 h.
Epifluorescence Microscopy and Steady-State Spectroscopy. Cells were incubated for 5 min in a 100 M solution of [PtL 1 Cl] in PBS solution, containing 1% DMSO (vol/vol) to facilitate solubilization of the complex. Control experiments confirmed that this concentration of DMSO had no adverse effect on cell viability as measured by MTT assay (Fig. 2) . After incubation, the solution containing the complex was removed, and the live cells were washed with PBS and transferred on a coverslip to the microscope stage for direct imaging without being fixed. An incubation time of only 5 min was sufficient to achieve maximal emission intensity of [PtLCl] in the cells, which is strikingly shorter than that for the previously explored cationic metal complexes (11) (12) (13) . The exceptionally short incubation time suggests that [PtL 1 Cl] is highly permeable across the plasma membrane of all three cell types studied and accumulates intracellularly under diffusion control. It is highly likely that no specific transmembrane transport mechanism is required, via membrane channels or receptor mediated endocytosis, and demonstrates the potential of these Pt(II) compounds for use as labels in a wide range of eukaryotic cell types.** The Pt(II) complex in the cells emits a characteristic green-toyellow light upon excitation. A typical spectrum of emitted light from stained CHO, HDF, and C8161 cell nuclei is essentially identical in profile to that of [PtL 1 Cl] in aqueous solution (Fig. 3 and Figs. S2 and S3), with the emission maxima in the range 490-550 nm. The characteristic vibrational structure of the emission spectrum, with the 0-0 band of the vibrational progression being the most intense, reflects the low degree of reorganization in the emissive excited state compared to the ground state. That a similar spectrum is obtained for the complex inside the cells to that in solution confirms convincingly that the ''PtL'' unit responsible for emission is retained intact within the cells.
An apparent preferential labeling of the nuclei was investigated by costaining experiments with the standard nuclear stain DAPI (4Ј,6-diamidino-2-phenylindole) performed by epifluorescence microscopy. Conveniently, the emission spectrum of [PtL 1 Cl] does not overlap with that of DAPI, and the former can be excited into the S 3 T absorption band centered at 488 nm where DAPI does not absorb, allowing for an independent visualization of the localization of both compounds within the cells. CHO or HDF cells were preincubated with [PtL 1 Cl] and fixed; this was followed by staining with 300 nM DAPI for 5 min. To investigate further the subcellular localization of the [PtL 1 Cl] chromophore, 15-30 orthogonal confocal 1-m z-images were taken for each cell type by using the above loading conditions. Representative images from each are shown in Fig. 5 , again confirming preferential labeling of the nuclei. Well defined regions of high-intensity emission were identified corresponding to nucleoli suborganelles (vide infra). Intensity plots were calibrated for each of the cell images, confirming predominant nucleoli localization, and are illustrated next to the [PtL 1 Cl] grayscale micrographs (Fig. 5) . Recent studies of nucleoli revealed structural organization around ribosomal repeat DNA gene clusters, which give rise to 28S, 18S, and 5.8S ribosomal RNAs. In turn, these are processed and assembled into ribosomes (24) . It is also known that during the cell cycle, nucleoli can exist either individually or in clusters. Confocal images of CHO, fibroblast, and C8161 cells identified cluster structures within the nuclei of all cells studied (Fig. 5) . Confocal image observations made are therefore consistent with intracellular binding to DNA and, because of the heterogeneous composition of the nucleoli, would also suggest that [PtL 1 Cl] may bind to RNA. The observed weak staining of the cytoplasm was not uniform. It was noted that the areas of brighter staining in the cytoplasm resembled structures likely to correspond to mitochondria, which would therefore also contain DNA.
Interaction of [PtL 1 Cl] with nucleic acids was confirmed by solution titrations with calf thymus and salmon sperm DNA in aqueous phosphate or Hepes buffer in the presence of NaCl. Emission of [PtL 1 Cl] was enhanced in the presence of nucleic acid, with a saturation ratio of Ϸ1:2.3 complex/DNA base pairs. An intercalative interaction is certainly plausible, given the structural similarity of the complex to platinum-terpyridine, a well established DNA intercalator (25) . In Pt-terpyridyl complexes, this initial noncovalent interaction may be followed by platination of the DNA through displacement of the chloride by the nitrogen atoms of nucleobases (26) . The higher lability of the Pt-Cl bond in [PtL 1 Cl] compared with Pt(N^N^N-tpy) complexes, arising from the trans effect of the cyclometallated carbon (27) , should strongly promote such a binding mode of the former to DNA. On these grounds, one may also suggest that binding to ribonucleic acids would also be possible, a proposition that might account for the observed presence of [ Lifetime imaging experiments on the live cells stained with [PtL 1 Cl] were performed by using pulsed laser excitation at 355 nm of pulse length Ϸ0.6 ns. Time-resolved images were obtained with a time-gated CCD camera, which allows a series of images to be recorded at different time delays after the excitation pulse (Fig. 6) .
A simple yet striking example of the power of time gating is demonstrated by low-resolution images obtained from cells pretreated with [PtL 1 Cl] in the presence of fluorescein dianion [ f ϭ 3.6 ns (30)], whose emission serves as a challenging model of short-lived background fluorescence. Immediately after the laser excitation pulse (Fig. 7 Left), little can be resolved because the fluorescein emission swamps the image. By activating the camera after a delay of 10 ns after the laser excitation pulse, the cells are visualized by the long-lived emission from the Pt(II) complex (Fig.  7 Right) . These experiments clearly show the possibility and power of imaging with [PtL 1 Cl] without interference from the autofluorescence background.
A representative set of time-resolved images obtained from the CHO cells preincubated with [PtL 1 Cl] within the time frame from 50 to 2900 ns after the laser pulse is shown in Fig. 8 . Remarkably, even 3 s after the excitation laser pulse, the image is still of sufficient contrast for the cells to be visualized.
The quantitative kinetics of the decay of the emission intensity could be readily monitored in different cells and within different regions within the same cell (Fig. 9) . The observed temporal decay in each case fits well to a biexponential function, where the † † The role of thiols in intracellular binding of [PtL 1 Cl] must also be considered. Given the soft, thiophilic nature of Pt(II), displacement of the chloride of [PtL 1 Cl] by the sulfur atom of cellular thiols, -SH, such as those of glutathione-or cysteine-containing proteins, might be anticipated within more reducing regions of the cell. Intracellular levels of reduced glutathione (GSH) are relatively high, Ϸ1-8 mM in most eukaryotic cell types (28) . Solution studies of [PtL 1 Cl] have revealed that replacement of the chloride by a thiolate ligand leads to a switch in the nature of the emissive state from a predominantly ligand-centered one to a charge transfer state. This switch is accompanied by a reduction of two orders of magnitude in the lifetime and a change from structured green to structureless red emission (max ϭ 680 -750 nm) (29) . The low-emission quantum yield of the CT state and its efficient quenching by oxygen and by water would make its detection within the cells difficult. However, we reasoned that such sulfur bonding could be manifest as a reduction in the concentration of available [PtL 1 Cl] for labeling of nitrogenous sites. In order to investigate the possibility that intracellular target sites might also include the reduced form of glutathione, two indirect approaches were used. (i) Exposure of cells to 100 M H2O2 for 1 h with the aim of oxidizing free thiol groups (i.e. rapid conversion of GSH to GSSG).
(ii) Incubation of cells with 500 M buthionine-(S,R)-sulfoximine (BSO) for 24 h, before treatment with the Pt complex. BSO is an inhibitor of ␥-glutamylcysteine synthetase and in turn depletes intracellular levels of total glutathione. In both cases, the cellular images obtained after treatment with H2O2 or BSO showed qualitatively higher contrast than their nonpretreated counterparts under identical experimental conditions (Figs. S4 and S5 ). The emission-spectral profiles and lifetimes, within experimental error, were not affected by the BSO or H2O2 pretreatment. This implies some degree of binding of [PtL 1 Cl] to free -SH groups. Thus, we could tentatively conclude that potential binding sites of the Pt(II) complexes include not only DNA and RNA but also, to a lesser extent, free thiol sites located on intracellular molecules such as GSH. That the emission does not follow the single exponential decay observed in solution is clearly a reflection of the disparate local environments and binding modes anticipated for the complex within the cell organelles. The observed biexponential fit is probably a simplest approximation to polyexponential decay kinetics arising from a distribution of environments, consistent with several subcellular structures being potential binding sites. Similar kinetic profiles could be obtained from HDF (Fig. S6 ) and melanoma C8161 (Fig. S7) cells. These data highlight the ease with which the kinetic profile can be generated on the time scale of several microseconds in TREM.
Live Cell Imaging Under TPE. The second major objective of our work, apart from the time-resolution, was to explore the possibility of TPE of these bright and photostable Pt(II) luminophores within live cells. This would bring into play the benefits of TPE described in the Introduction, most importantly the intrinsic high resolution, and ability to excite labeling agents at low energies in the near-IR.
Determination of the Two-Photon Absorption Cross-Section of [PtLCl].
The two-photon absorption cross-section, ␦, of the Pt(II) complexes was determined by monitoring the emission intensity in DMF solution under 790-nm excitation, by using fluorescein and rhodamine-B as standards. The value of 4 (Ϯ2) ϫ 10 Ϫ50 cm 4 s per photon (4 GM) obtained is lower than that of fluorescein but easily sufficient for practical applications. The two-photon nature of the excitation process was confirmed by the quadratic increase of the intensity of emitted light with the increase in laser power. The emission lifetime measured after excitation at 790 nm was identical to that observed under one-photon excitation at 355 nm, confirming that the same excited state was formed in both cases.
High-Resolution Confocal Imaging Under Two-Photon Excitation. Two photon excitation of [PtL 1 Cl] in live CHO cells was accomplished by using a mode-locked Ti-sapphire laser operating at 758 nm. High-resolution images of the cells were generated by raster scanning of the laser spot in the xy plane (Fig. 10) . The images clearly confirm the preferential localization of the chromophore in the nucleoli that had been observed in the linear confocal experiments described above. The results demonstrate the viability of TPE of the platinum complexes in live cells, with apparently no short-term detrimental effect on the cells. To the best of our knowledge, this two-photon imaging in live cells by using transition-metal complexes has not been described before.
Conclusions
This work opens up the microsecond domain in imaging, including that of biological structures, and may be best described as time-resolved emission imaging microscopy (TREM). The previous obstacles to practical TREM have been overcome by the development of brightly emissive, photostable and low-cytotoxic Pt(II) complexes as imaging agents for live cells cultured in vitro. The exceptionally high emission quantum yields and appropriately long lifetimes of these chromophores allowed for gated emission experiments and time-resolved lifetime-based imaging on a hitherto uncharted time scale. These small, charge-neutral compounds are remarkable in their simplicity and in the ease with which they can be synthesized and derivatized, should specific targeting be required.
Maximum emission intensity within all cell types studied-CHO, HDF and melanoma C8161-was achieved within a strikingly short incubation period of 5 min, implying that no specific transmembrane transport mechanism is required and that the compounds may be amenable to use as labels in any eukaryotic cell types. The photostability of [PtL 1 Cl] under prolonged intense irradiation allowed, for the first time, the use of NIR TPE in conjunction with transition-metal complexes in live cells. The high-resolution two-photon images confirmed the preferential accumulation of the Pt(II) complex in the nuclei and, in particular, in the nucleoli. The intracellular preferential target site proposed for [PtL 1 Cl] is DNA, which may extend to RNA.
The work shows the power of lifetime mapping and TPE for imaging of live cells and provides an approach for noninvasive imaging of many hundreds of micrometers into complex biological structures. Extension to antibody conjugation, where high fluorophore photostability is essential, can be anticipated. The great potential of transition metal complexes for these applications is clear.
Materials and Methods
The platinum(II) complexes were prepared as described (20, 21) .
The details of cell culture sources and handling are described in SI Text.
Confocal and Epifluorescent Imaging Under One-Photon Excitation and Costaining.
A Zeiss LSM 510 confocal microscope with magnification ϫ20 and ϫ40 long-range water-dipping lenses was used.
[PtLCl] in cells were excited with an Ar-ion laser at 488 nm, emission was monitored through a 505-to 530-nm filter reflected from a 545-nm dichroic mirror. Image data acquisition and analysis were carried out with Carl Zeiss Laser Scanning Systems LSM 510 software, version 3.2. Epifluoresecnce microscopy was carried out by using a Leica-DM-IRB inverted microscope using epifluorescent illumination and a magnification 100ϫ oil-immersion lens at 485 nm and acquisition at 520 nm for [PtLCl] and illumination at 400 nm and acquisition at 460 nm for DAPI-labeled nuclei. Two-photon cross-sections were measured in 40 M DMF solution as described by Xu and Webb (31) using an 8-W 532-nm (Verdi; Coherent) pumped Mira 900-F Ti-sapphire laser producing 180-fs pulses at 790 nm using fluorescein as a standard (␦ ϭ 38 Ϯ 9.7 GM). The laser light was focused onto the stage of an inverted microscope (Nikon TE2000U) using a magnification ϫ40, N.A. 0.9 microscope objective. The fluorescence was collected by the same objective, through a dichroic mirror (660IK; Comar) and imaged onto a fast micro channel plate photo multiplier tube (PMT). The signal from the PMT was synchronized to the laser pulses by using a Becker-Hickl SPC700 timecorrelated single-photon counting module. Relative absorption cross-section (␦) values of rhodamine B and fluorescein were first determined to ensure that the experimental setup yielded data consistent with those previously reported in the literature (31) . The uncertainty in the ␦ value arises from the usual difficulties of calibration in such measurements, augmented by the number of corrections required for the effects of oxygen and intermolecular selfquenching on lum (21) .
Time-Resolved Imaging Experiments. The actively Q-switched nanosecond AOT-YVO-20QSP/MOPA Nd/vanadate diode pumped microlaser with repetition rate (1-20 kHz), short pulse duration (0.6 ns), 355 nm (12 mJ per pulse) was operated in the external trigger mode. Pulses generated from a Stanford DG535 pulse delay generator (PDG) were used as the trigger signals for the laser. The 355-nm laser pulses were directed to the epifluorescence port of the microscope (TE200U; Nikon) and reflected off a dichroic mirror (410BK; Comar) and into the back aperture of a magnification ϫ40 lens (N.A. 0.9). Phosphorescence from the sample was collected by the same objective and imaged onto a subnanosecond-gated intensified CCD (Andor iStar) with delays set by the PDG and synchronized to the nanosecond laser. The laser light was blocked by using a 420GY (Comar) filter in front of the CCD camera. The three exit ports of the microscope were used to direct the output to the gated CCD camera, a steady-state Q-Cam 10-bit color camera, or an iDus CCD camera, depending on the particular observation mode. For the gated CCD, typical exposure time was 0.02 s, the number of accumulations varied from 5 to 20. The principle of time gating is demonstrated in Fig. 6 . By monitoring ''time slices'' at increasing intervals after the pulse, e.g., every 100 ns, the intensity of the image can be monitored as a function of time.
Imaging under TPE was performed by using the Ti-sapphire laser and inverted microscope described above. Images were generated point-by-point by raster scanning of the laser spot by using an x,y galvanometer (GSI Lumonics), and fluorescence was detected using the Hamamatsu PMT (R3809U) operating in single-photon counting mode. 
